Login / Signup

C-reactive protein levels and prevalence of leukopenia in patients with inflammatory bowel disease treated with azathioprine and/or mesalazine: a real-life study.

Rejani Cristine Faustino Dos SantosWilson Roberto CatapaniAndré Akira Ramos TakahashiJaques Waisberg
Published in: Einstein (Sao Paulo, Brazil) (2022)
Regardless of symptoms, serum C-reactive protein levels were not a reliable indicator of controlled inflammatory bowel disease. Leukopenia was independently associated with older age and higher doses of medication and is a common side effect, which should be routinely monitored.
Keyphrases
  • patients with inflammatory bowel disease
  • risk factors
  • healthcare
  • physical activity
  • emergency department